What development phase is PIRMENOL in?

PIRMENOL is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

PIRMENOL

FDA-approved active Small molecule Quality 19/100

At a glance

Generic name	PIRMENOL
Drug class	pirmenol
Target	Sodium channel protein type 5 subunit alpha
Modality	Small molecule
Therapeutic area	Cardiovascular
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PIRMENOL CI brief — competitive landscape report
PIRMENOL updates RSS · CI watch RSS